Philips Recognized with ‘A’ Score for its Climate Action Leadership

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that the company has been recognized for its climate action leadership by global environmental non-profit CDP. Thanks to its actions to cut emissions, mitigate climate risks, and develop the low-carbon economy, Philips has secured a place on CDP’s ‘A List’ for the ninth consecutive year.

“With health systems and consumers increasingly committed to making more sustainable choices and to climate action, we remain convinced that doing business sustainably is the only way forward,” said Frans van Houten, CEO of Royal Philips. “Our ongoing actions to embed sustainability in our solutions, our operations, and across the supply chain, have once again been recognized with a place on CDP’s prestigious benchmark. I am proud that the creativity and inspiration of our global workforce continue to make a difference in creating a healthier and more sustainable world.”

CDP’s annual environmental disclosure and scoring process is widely recognized as the gold standard of corporate environmental transparency. Its scoring methodology assesses companies on the comprehensiveness of their disclosure, awareness and management of environmental risks and demonstration of best practices associated with environmental leadership, such as setting ambitious and meaningful targets.

Global recognition

To achieve its vision of making the world healthier and more sustainable through innovation, Philips employs a comprehensive set of commitments across all the Environmental, Social, and Governance (ESG) dimensions that guide the execution of company strategy. Philips is already carbon neutral in its operations and is set to further reduce its CO2 emissions in line with 1.5°C global warmings, for example by further improving the energy efficiency of its products during the customer use phase and teaming up with customers and stakeholders to decarbonize healthcare. The company has also set ambitious circular economy objectives, such as generating 25% of its revenue from circular products, services and solutions by 2025. Philips is also taking action to drive the significant reduction of greenhouse gas emissions in its supply chain.

The company’s longstanding commitment to doing business responsibly and sustainably has received widespread recognition. For example, Philips has achieved top positions in the global Dow Jones Sustainability Indices and Sustainalytics rankings, and the company was awarded a top ESG score of 90 out of 100 by S&P Global Ratings. Moreover, Philips was the first health technology company to have its carbon emission targets for the 2020 – 2040 period assessed and approved by the Science-Based Targets initiative (STBi). 

More information about how Philips is partnering with stakeholders to drive environmental, social, and governance priorities and make a global impact, is available here.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”